Elliot Tapper: Continuing Anticoagulation Improves PVT Outcomes During Banding
Elliot Tapper, Academic Chief of Hepatology and Andrews Family Research Professor at the University of Michigan, shared a post on LinkedIn about a recent article by Yingying He et al. published in Therapeutic Advances in Gastroenterology, adding:
“Thing we do for no reason?
A trial assessed continuing vs stopping anticoagulation in patients with portal vein thrombosis undergoing banding
AC: enoxaparin
Mixed pop of acute bleeding and secondary prophylaxis
Continuing AC better.”
Title: Continuous versus intermittent anticoagulation during endoscopic treatment of esophageal varices in cirrhosis: a randomized controlled trial
Authors: Yingying He, Zhihong Wang, Jiayi Zhang, Qianqian Zhang, Yaxian Kuai, Yuchuan Bai, Xuecan Mei, Derun Kong

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026